Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 4, 2024Zagazig University Medical Journal

Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

HAHala A Abdel-AzeezZagazig UniversitySESahar EldeebZagazig UniversityDADina M. AtefZagazig University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abdel-Azeez et al. (2024) studied this question.

synapsesocial.com/papers/68e70792b6db643587681aa8https://doi.org/10.21608/zumj.2024.280851.3304
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Estimation of Some Biomarkers in Type 2 Diabetic Patients for Detection Early Incidence of Diabetic Nephropathy2025
  2. 2The Role of Fibroblast Growth Factor 23 as a Marker of Early Renal Impairment in Children with Type 1 Diabetes Mellitus2025
  3. 3The Promising Role of Selected Fibroblast Growth Factors as Potential Markers of Complications in Type 1 and Type 2 Diabetes2025 · 1 citations
  4. 4Role of Beta Trace Protein and Cystatin C as a Potential Biomarker for Early Detection of Type 2 Diabetic Nephropathy2024 · 4 citations
  5. 5Association of serum fibroblast growth factor 19 with DKD as assessed by the UACR and eGFR in patients with type 2 diabetes2026